Polycystic ovarian syndrome - management and treatment
Keywordspolycystic ovarian syndrome, endocrine productive disorder, infertility, hyperandrogenism, hormonal contraceptive, metformin, clomifene citrate
The polycystic ovarian syndrome is an endocrine disorder with a high prevalence affecting reproductive-aged women and adolescent girls. The most common symptoms are infertility, numerous ovarian cysts, hyperandrogenism, menstrual cycle abnormalities. The disease has a great impact on patients, impairing their quality of life. Bearing that in mind, innovative therapeutic approaches are needed. We aim to describe current management and treatment concepts adopted in PCOS therapy. The analysis of previously published studies was conducted by using the PubMed, Google Scholar, and Scopus databases.
Mentioned studies show that lifestyle changes may benefit PCOS therapy in multiple ways. Dietary and exercise interventions have a notable influence on women’s body composition as well as biochemical parameters. The reduction of body weight or BMI is a therapeutic achievement likewise patients’ contribution to managing PCOS. Pharmacotherapy provides plentiful treatment choices to adopt. Studies show that hormonal contraceptive has a significant impact on both hyperandrogenism and menstrual abnormalities. Metformin is proven to reduce BMI, improve LDL levels, and lower the risk of OHSS in women undergoing IVF/ICSI-ET. A meta-analysis proved metformin’s monotherapy superiority over clomifene citrate or their combination in treating infertility. However, both substances are not recommended as the first-line choice. Regrettably, many studies mention short of evidence, lack of larger sample sizes, or insufficient duration preventing further research.
The conclusion we draw is that approaches of managing and treating PCOS are constantly advancing and updating. However, there is a necessity for future studies to expand their research by gathering more data and considering diverse cases.
Pena, A.S., et al., Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med, 2020. 18(1): p. 72.
Stankiewicz, M. and R. Norman, Diagnosis and management of polycystic ovary syndrome: a practical guide. Drugs, 2006. 66(7): p. 903-12.
Norman, R.J. and H.J. Teede, A new evidence-based guideline for assessment and management of polycystic ovary syndrome. Med J Aust, 2018. 209(7): p. 299-300.
Duijkers, I.J. and C. Klipping, Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. Gynecol Endocrinol, 2010. 26(3): p. 152-60.
Pehlivanov, B. and M. Orbetzova, Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol, 2007. 23(10): p. 604-9.
Timpatanapong, P. and A. Rojanasakul, Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. J Dermatol, 1997. 24(4): p. 223-9.
Morgante, G., et al., Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. Minerva Ginecol, 2015. 67(5): p. 457-63.
Wu, Z.H., et al., Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis. J Ovarian Res, 2019. 12(1): p. 94.
Greenwood, E.A., et al., Insulin resistance is associated with depression risk in polycystic ovary syndrome. Fertil Steril, 2018. 110(1): p. 27-34.
Gibson-Helm, M., et al., Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab, 2017. 102(2): p. 604-612.
Goodman, N.F., et al., American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome--Part 1. Endocr Pract, 2015. 21(11): p. 1291-300.
Moran, L.J., et al., Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev, 2011(7): p. CD007506.
Benham, J.L., et al., Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis. Clin Obes, 2018. 8(4): p. 275-284.
Dos Santos, I.K., et al., The effect of exercise as an intervention for women with polycystic ovary syndrome: A systematic review and meta-analysis. Medicine (Baltimore), 2020. 99(16): p. e19644.
Shang, Y., et al., Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome. J Clin Endocrinol Metab, 2020. 105(10).
Legro, R.S., et al., Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2013. 98(12): p. 4565-92.
Al Khalifah, R.A., et al., Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis. Pediatrics, 2016. 137(5).
Wu, Y., et al., Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization: A Systematic Review and Meta-analysis. JAMA Netw Open, 2020. 3(8): p. e2011995.
Palomba, S., et al., Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. Clin Endocrinol (Oxf), 2009. 70(2): p. 311-21.
Amiri, M., et al., Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Contracept Reprod Health Care, 2018. 23(1): p. 64-77.
How to Cite
Copyright (c) 2021 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 339
Number of citations: 0